BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Level 2 Lite

1 year 40%, 2 years 50% and *3 years 60%
EU Flag

*Across 3 years £2132.64 only £853.06

ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,132.10
0.58%
Dow Jones
43,677.31
0.62%
Gold vs US Dollar
2,669.085
0.63%
Brent Oil
73.745
1.24%
Bitcoin
96,652.77
2.43%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Germany
  5. TG
  6. Ackermans and Van Haaren NV (B3K)

  7. Ackermans and Van Haaren NV (B3K) News

B3K Ackermans and Van Haaren NV

187.80
1.60 (0.86%)
15:55:11 - Realtime Data
Share Name Share Symbol Market Type
Ackermans and Van Haaren NV TG:B3K Tradegate Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.60 0.86% 187.80 188.00 188.20 187.80 186.40 186.40 136 15:55:11

Ackermans & van Haaren mène une levée de fonds de série B de 60 millions d'euros pour Confo Therapeutics, une société biopharmaceutique belge

26/07/2024 6:00am

UK Regulatory


Ackermans and Van Haaren... (TG:B3K)
Historical Stock Chart


From May 2024 to Nov 2024

Click Here for more Ackermans and Van Haaren... Charts.
Ackermans & van Haaren mène une levée de fonds de série B de 60 millions d'euros pour Confo Therapeutics, une société biopharmaceutique belge

Cher actionnaire,

Monsieur, Madame,


veuillez trouver ci-joint notre communiqué.


Meilleures salutations,

Ackermans & van Haaren


Pièce jointe

  • Ackermans & van Haaren mène une levée de fonds de série B de 60 millions d'euros pour Confo Therapeutics (communiqué de presse 26 juillet 2024)

1 Year Ackermans and Van Haaren... Chart

1 Year Ackermans and Van Haaren... Chart

1 Month Ackermans and Van Haaren... Chart

1 Month Ackermans and Van Haaren... Chart

Your Recent History

TG
B3K
Ackermans and Van Haaren...
DGFX
BTCUSDT
Bitcoin
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Level 2 Lite

    1 year 40%, 2 years 50% and *3 years 60%
    EU Flag

    *Across 3 years £2132.64 only £853.06